| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0008 |